$74.56 +0.35 (%) Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca At European Cancer Symposium

    Benzinga | Nov. 20, 2014 | 16:48PM EST
  2. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  3. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  4. Bank Of America Believes DAPT Adds To Precedent For PEGASUS Success For AstraZeneca

    Benzinga | Nov. 17, 2014 | 10:29AM EST
  5. Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca

    Benzinga | Nov. 14, 2014 | 09:38AM EST
  6. Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis

    Benzinga | Nov. 11, 2014 | 16:03PM EST
  7. Blackhill Bets Almost Half of Portfolio on Williams-Sonoma

    GuruFocus | Nov. 10, 2014 | 16:00PM EST
  8. A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

    GuruFocus | Nov. 9, 2014 | 18:16PM EST
  9. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  10. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  11. #PreMarket Primer: Friday, November 7: Boehner Reveals Intentions To Modify Obamacare

    Benzinga | Nov. 7, 2014 | 07:50AM EST
  12. Will Pfizer Sweeten Its Bid For AstraZeneca?

    IBD | Nov. 6, 2014 | 18:41PM EST
  13. Divided Government Won't Halt Wall Street's Run

    FoxBusiness | Nov. 6, 2014 | 09:58AM EST
  14. #PreMarket Primer: Thursday, November 6: Obama, McConnell Prepare For Rocky Road Ahead

    Benzinga | Nov. 6, 2014 | 08:08AM EST
  15. AstraZeneca Raises 2014 Outlook

    Benzinga | Nov. 6, 2014 | 06:14AM EST
  16. Markets Rally On Better-Than-Expected GDP; Dow Has Best Close In Over A Month

    Benzinga | Oct. 30, 2014 | 17:09PM EST
  17. Eliquis revives Bristol-Myers

    IBD | Oct. 24, 2014 | 18:27PM EST
  18. Bristol-Myers Beats Q3 Views As Eliquis Revives

    IBD | Oct. 24, 2014 | 13:23PM EST
  19. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  20. Illumina Helps Make Gene Sequencing Affordable

    IBD | Oct. 17, 2014 | 18:48PM EST
  21. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  22. Illumina Pads Gene Sequencing Lead With Pharma Deals

    IBD | Oct. 8, 2014 | 16:04PM EST
  23. Actavis, Jazz, Novo Lead Top World Stocks List

    IBD | Oct. 7, 2014 | 18:08PM EST
  24. Actavis rival results positive

    IBD | Oct. 1, 2014 | 18:43PM EST
  25. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 12:10PM EST
  26. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  27. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  28. European Stocks Fall Most In 11 Weeks; CAC-40 Off 1.9%

    IBD | Sep. 23, 2014 | 18:48PM EST
  29. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  30. Inversions Thwarted, But Real Tax Fix Needs Congress

    IBD | Sep. 23, 2014 | 18:28PM EST
  31. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  32. Pfizer Inc. Is Kicking The Tires At Actavis PLC

    Benzinga | Sep. 23, 2014 | 14:45PM EST
  33. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  34. Midday Losers From September 23 - Alco Stores Inc, CarMax, Inc And More

    Benzinga | Sep. 23, 2014 | 12:37PM EST
  35. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  36. Drug giants target Alzheimer's

    IBD | Sep. 16, 2014 | 18:49PM EST
  37. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  38. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  39. Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca

    Benzinga | Sep. 3, 2014 | 05:10AM EST
  40. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga | Sep. 2, 2014 | 15:35PM EST
  41. AstraZeneca

    IBD | Aug. 29, 2014 | 18:54PM EST
  42. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline

    Benzinga | Aug. 27, 2014 | 11:25AM EST
  43. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  44. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  45. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga | Aug. 25, 2014 | 16:03PM EST
  46. Illumina lines up key partners

    IBD | Aug. 21, 2014 | 18:41PM EST
  47. Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole

    Benzinga | Aug. 21, 2014 | 17:16PM EST
  48. Illumina Forms Partnerships With Big Pharma Firms

    IBD | Aug. 21, 2014 | 12:03PM EST
  49. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga | Aug. 21, 2014 | 11:39AM EST
  50. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD | Aug. 21, 2014 | 10:35AM EST
Trading Center